Haemonetics (HAE) Net Income towards Common Stockholders (2009 - 2026)
Haemonetics (HAE) posted Net Income towards Common Stockholders of $33.01 million for fiscal Q1 2027 (quarter ended Jun 27, 2026), down 3.0% from $34.03 million a year earlier.
Powered by 
Analysis
Haemonetics (HAE) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 27, 2026, Net Income towards Common Stockholders at Haemonetics was $96.29 million, down 41.1% year-over-year; for FY2026 (ended Mar 28, 2026), it was $97.31 million, down 42.0% from FY2025.
- Annual Net Income towards Common Stockholders shows a five-year compound annual growth rate of 4.1% (FY2021 to FY2026).
- In prior fiscal years, Haemonetics' Net Income towards Common Stockholders was $167.68 million in FY2025 (+42.6%), $117.56 million in FY2024 (+1.9%), $115.4 million in FY2023 (+166.1%) and $43.38 million in FY2022 (-45.4%).
- Quarterly Net Income towards Common Stockholders has run from a low of -$20.15 million in fiscal Q4 2026 to a high of $57.98 million in fiscal Q4 2025 over five years.
- On a year-over-year basis, Net Income towards Common Stockholders increased in five of the last seven quarters, with growth averaging 37.1%.
- The strongest year-over-year quarter for Net Income towards Common Stockholders in the past five years was fiscal Q4 2023, with growth of 201.6%; the weakest was fiscal Q2 2022, with a decline of 69.1%.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior fiscal quarters was -$20.15 million (Q4 2026), $44.74 million (Q3 2026) and $38.68 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 1.74 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 928.00 Mn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 870.00 Mn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 818.10 Mn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 1.47 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 1.28 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 907.00 Mn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 241.90 Mn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 377.00 Mn |
| 10 | Haemonetics | 4.76 Bn | 3.63 Bn | 202.80 Mn | 33.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 33.01 Mn |
| Mar 28, 2026 | -20.15 Mn |
| Dec 27, 2025 | 44.74 Mn |
| Sep 27, 2025 | 38.68 Mn |
| Jun 28, 2025 | 34.03 Mn |
| Mar 29, 2025 | 57.98 Mn |
| Dec 28, 2024 | 37.49 Mn |
| Sep 28, 2024 | 33.83 Mn |
| Jun 29, 2024 | 38.37 Mn |
| Mar 30, 2024 | 20.37 Mn |
| Dec 30, 2023 | 31.24 Mn |
| Sep 30, 2023 | 24.91 Mn |
| Jul 1, 2023 | 41.04 Mn |
| Apr 1, 2023 | 29.38 Mn |
| Dec 31, 2022 | 32.94 Mn |
| Oct 1, 2022 | 33.20 Mn |
| Jul 2, 2022 | 19.88 Mn |
| Apr 2, 2022 | 9.74 Mn |
| Jan 1, 2022 | 23.23 Mn |
| Oct 2, 2021 | 14.86 Mn |
API Access
Haemonetics Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=HAE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "HAE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=HAE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();